The reported expression of EGFR ranges from 8 to 100%, HER-2 from 1% to 89%, HER-3 from 16 to 89%, and HER-4 from 11 to 81% in colorectal cancer patients [6], [14]–[16], [20]–[22], [38]. Here, ERBB3 is linked to colorectal cancer.